4. MEDICATION ABORTION
Updated June 2022, by Deyang Nyandak MD, Hannah Biederman MD, and Hannah Rosenfield MD
Medication abortion (MAB), which includes the use of mifepristone and misoprostol or misoprostol alone, provides a safe, effective method of pregnancy termination. MAB is increasing globally and in the U.S.. It can be offered in diverse settings without special equipment. This process allows for significant patient autonomy with appropriate education and follow-up as needed.
CHAPTER LEARNING OBJECTIVES
At the end of this chapter you should be able to:
- Evaluate patients prior to MAB
- Effectively counsel patients regarding MAB
- Discuss criteria for needing additional MAB follow-up, and manage it as needed
- Provide teleMAB (telemedicine medication abortion) to appropriate patients
VIDEOS
NEW VIDEO-BASED MEDICATION ABORTION IN PRIMARY CARE CME |
Here you can learn evidence-based ways to:
|
READING / RESOURCES
- NAF Clinical Practice Guidelines – Early Medication Abortion (NAF 2022)
- WHO Abortion Care Guideline (WHO 2022)
- Medical Management of First-Trimester Abortion (SFP Clinical Guidelines 2014)
- Ipas Clinical Updates in Reproductive Health: Medication Abortion (Ipas 2021)
- Mifepristone manufacturers (with on-call networks) Danco (https://www.earlyabortionpill.com) and GenBioPro (https://genbiopro.com)
- Additional helpful resources for providers and patients:
- Access Delivered Medication Abortion Provider Toolkit
- RHAP Provider Abortion Resources
- RHAP Patient Resource: Sam’s Medication Abortion Zine
- Euki App – a private sexual and reproductive health app